Frontiers in fungal biology · 2026
Interplay between CARD9 genetic variants and fungal colonization patterns among patients with diabetes.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Khateb Aiah M, Alharbi Rahaf Ghazi, Alsweed Lujain, Doud Mohammed, Almuzaini Khlood F, Alzahrani Abdulwahab, Fallatah Sultan, Yasir Muhammad, Azhar Esam I
Аннотация
BACKGROUND: Diabetes mellitus significantly increases susceptibility to opportunistic fungal colonization; however, the genetic architecture underlying this vulnerability in Middle Eastern populations remains underexplored. Caspase recruitment domain-containing protein 9 (CARD9) is a fundamental adaptor in fungal sensing. While CARD9 deficiency is traditionally viewed as a rare pediatric immunodeficiency, we hypothesize that common CARD9 variants serve as significant predisposing factors for fungal burden in the adult diabetic population.
METHODS: A cohort of 107 diabetic participants (49.5% overweight/obese) was screened for fungal colonization across multiple anatomical sites. Targeted sequencing of the CARD9 gene was performed, using a bioinformatics pipeline for heterozygous peak calling (IUPAC ambiguity codes) and Ensembl VEP for variant annotation. Functional impacts were predicted using SIFT, PolyPhen-2, and PyMOL structural modeling.
RESULTS: Fungal colonization was prevalent, with Aspergillus niger complex (27.9%) being the most frequently identified organism. Genomic analysis identified the N-terminal CARD domain as a mutational "hotspot." We identified a high prevalence of homozygous damaging variants (52.7%), including p.Arg47His and p.Gly49Asp, which disrupt CARD domain stability. An additional 24.8% of the cohort displayed significant IUPAC-mixed heterozygous signals. Despite these genetic findings, a "paradox of stability" emerged: individuals with the highest microbial scores (4-5) often carried the reference sequence, while multivariate analysis identified obesity (OR: 1.85, p < 0.05) as the primary independent predictor of fungal burden.
CONCLUSION: Our findings demonstrate that the diabetic population harbors a widespread, previously unrecognized deficiency in the Dectin-1/CARD9 signaling pathway. This shifts the clinical narrative of CARD9 from a "rare pediatric disease" to a common genetic predisposition in adult patients with diabetes. While metabolic dysregulation may override genetic factors, the high frequency of CARD domain "hotspot" mutations supports a precision medicine approach integrating CARD9 genotyping with metabolic profiling to risk-stratify patients for early antifungal prophylaxis.
METHODS: A cohort of 107 diabetic participants (49.5% overweight/obese) was screened for fungal colonization across multiple anatomical sites. Targeted sequencing of the CARD9 gene was performed, using a bioinformatics pipeline for heterozygous peak calling (IUPAC ambiguity codes) and Ensembl VEP for variant annotation. Functional impacts were predicted using SIFT, PolyPhen-2, and PyMOL structural modeling.
RESULTS: Fungal colonization was prevalent, with Aspergillus niger complex (27.9%) being the most frequently identified organism. Genomic analysis identified the N-terminal CARD domain as a mutational "hotspot." We identified a high prevalence of homozygous damaging variants (52.7%), including p.Arg47His and p.Gly49Asp, which disrupt CARD domain stability. An additional 24.8% of the cohort displayed significant IUPAC-mixed heterozygous signals. Despite these genetic findings, a "paradox of stability" emerged: individuals with the highest microbial scores (4-5) often carried the reference sequence, while multivariate analysis identified obesity (OR: 1.85, p < 0.05) as the primary independent predictor of fungal burden.
CONCLUSION: Our findings demonstrate that the diabetic population harbors a widespread, previously unrecognized deficiency in the Dectin-1/CARD9 signaling pathway. This shifts the clinical narrative of CARD9 from a "rare pediatric disease" to a common genetic predisposition in adult patients with diabetes. While metabolic dysregulation may override genetic factors, the high frequency of CARD domain "hotspot" mutations supports a precision medicine approach integrating CARD9 genotyping with metabolic profiling to risk-stratify patients for early antifungal prophylaxis.